N-Benzyl-(2,5-dioxopyrrolidin-1-yl)propanamide (AS-1) with Hybrid Structure as a Candidate for a Broad-Spectrum Antiepileptic Drug
Krzysztof Kamiński(Jagiellonian University), Piotr Właź(Maria Curie-Skłodowska University)
Cited by 27
Related Papers
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
|Pharmacological Research|2021|779
Discovery of (<i>R</i>)-<i>N</i>-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [<b>(<i>R</i>)-AS-1</b>], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity <i>In Vivo</i>
|Journal of Medicinal Chemistry|2022|22
Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides
|Molecules|2021|16
Blebbistatin reveals beneficial effects on the cystometric parameters in an animal model of detrusor overactivity
|Naunyn-Schmiedeberg s Archives of Pharmacology|2019|3